SNCA and Parkinson disease: By inhibiting SP1, a transcription factor expressed in the brain, miR-375 decreases dopaminergic neurons’ damage, reduces oxidative stress, and diminishes inflammation in PD, and miR-29c also attenuates dopaminergic neuron loss, neuroinflammatory response, and α-synuclein accumulation [187,188].